Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-16 08:00:47 EDT

PhotosVideosAllPeople
LatestRanked
@thelancetendo.bsky.socialOct 14, 2026, 10:43 AM

Also read the original Viewpoint article:
Goal-directed #osteoporosis treatment: are bone mineral density targets valid? thelancet.com/journals/lan...
#BMD
#OpenAccess
#MedSky #EndoSky #RheumSky

@thelancetendo.bsky.socialOct 14, 2026, 10:43 AM

Ian R Reid responds to Eastell et al:
Bone mineral density as a surrogate endpoint in #osteoporosis trials – Author's reply thelancet.com/journals/lan...
#BMD
#FREE to read
#MedSky #EndoSky #RheumSky

@thelancetendo.bsky.socialOct 14, 2026, 10:43 AM

New in the November Issue:
Richard Eastell & colleagues correspond on:
Bone mineral density as a surrogate endpoint in #osteoporosis trials thelancet.com/journals/lan...
#BMD
#FREE to read
#MedSky #EndoSky #RheumSky

@thelancetendo.bsky.socialOct 13, 2026, 10:33 PM

Read our November Issue, featuring type 2 diabetes in Mauritius, obesity, glucagon, SGLT2 inhibitors, ketoacidosis, hypoparathyroidism, adiposity, disease modification outcomes in type 2 diabetes, paediatric metabolic health, & much more tinyurl.com/mwfu4c6m

#MedSky #EndoSky #RheumSky #GastroSky

Photo, no description
@papertis.bsky.socialOct 12, 2026, 1:03 PM

Tapering DMARDs in RA in sustained control?

27 publications, 5,262 patients (RCTs): tapering raised flare risk (RR 1.56), withdrawal more (RR 2.23), mainly with biologics. Neither cut adverse events.

Zhang, Xu et al. Clin Transl Sci 2026

https://pubmed.ncbi.nlm.nih.gov/42836514/
#MedSky #RheumSky

De-escalating DMARDs in controlled rheumatoid arthritis. Clin Transl Sci 2026, meta-analysis of RCTs, 27 publications, 5,262 patients. Risk ratio for flare vs continuing: withdrawal 2.23, tapering 1.56. Mainly driven by biologics; neither strategy reduced adverse events.
@mithurheum.bsky.socialOct 7, 2026, 5:35 PM

🆕 Obesity Part 1: Collaboration with @rheumnow.bsky.social 🔵

GLP-1 Receptor Agonist Therapy in #Rheumatology 💉

⚖️ Effects through weight loss + possible weight-independent effects
🫀 Impact on Multiple Organ Systems
🎲 RCT Data of GLP-1 RA Therapy in OA & PsA

#RheumSky #Obesity #OA #PsA #GLP1

Photo, no description
@thelancetrheum.bsky.socialOct 6, 2026, 1:46 PM

NEW—CAR T cells for autoimmune diseases: 2026 update of the EBMT–ISCT–JACIE practice harmonisation and consensus recommendations bit.ly/4rMqjLy
#MedSky #RheumSky #NeuroSky #HaemSky

Photo, no description
@springermedicine.comOct 3, 2026, 3:15 PM

#MedCase - Progressive dyspnea in a young man was initially attributed to pleural and infectious causes, but further testing led to a diagnosis of probable shrinking lung syndrome and eventually of #SLE after the emergence of systemic features.

👉️ buff.ly/fnPTTW5

#RheumSky

@thelancetrheum.bsky.socialOct 2, 2026, 10:59 AM

NEW in @thelancet.com—Physiotherapist-led care for musculoskeletal conditions in the emergency department (RESHAP-ED): a randomised controlled trial with economic evaluation www.thelancet.com/journals/lan... #MedSky #RheumSky #PhysioSky

Photo, no description
@springermedicine.comOct 1, 2026, 8:01 AM

Delve into the evidence for coronary microvascular dysfunction and subclinical myocardial involvement in GPA.

Could an immunocardiology framework for individualized cardiovascular assessment be useful?

👉️ buff.ly/EFEXu08

#RheumSky #CardioSky

@springermedicine.comSep 30, 2026, 6:25 PM

What is the optimal diagnostic strategy for rheumatoid arthritis-associated interstitial lung disease?

This review assesses the reliability, validity, and clinical utility of the currently available methods and biomarkers.

👉️ buff.ly/h1tinpS

#RheumSky #PulmSky

@drmapaley.bsky.socialSep 29, 2026, 8:22 PM

(4/4) #Rheumsky #axSpA

Photo, no description
@drmapaley.bsky.socialSep 29, 2026, 8:22 PM

(3/4) #Rheumsky #axSpA

Photo, no description
@drmapaley.bsky.socialSep 29, 2026, 8:22 PM

(2/4) #Rheumsky #axSpA

Photo, no description
@drmapaley.bsky.socialSep 29, 2026, 8:22 PM

You can now view our abstract using this link and the summary images below: www.biorxiv.org/content/10.6...

@obigriffith.bsky.social @malachigriffith.bsky.social @thehumanborch.bsky.social

#Rheumsky #axSpA
(1/4)

Photo, no description
@thelancetrheum.bsky.socialSep 29, 2026, 3:21 PM

NEW RESEARCH—Predicting prevalence and severity of cytokine release syndrome after CAR T-cell therapy in patients with autoimmune disease: a retrospective cohort study bit.ly/4hujPwa

Plus, linked Comment bit.ly/4hrWLy8
#MedSky #RheumSky

Incidence of cytokine release syndrome after autologous CAR T-cell therapy by baseline biomarker. Concentrations are log scales. Dots indicate individual patients and error bars indicate 95% CIs.
@springermedicine.comSep 29, 2026, 10:54 AM

#MedNews - A phase 1 study has shown initial evidence that A-319, a bispecific T-cell engager, is well tolerated by patients with systemic lupus erythematosus and efficacious.

👉️ buff.ly/Kg5oa0H

#RheumSky #Lupus

@springermedicine.comSep 29, 2026, 8:01 AM

#MedCase - A man presenting with bilateral epididymo-orchitis and high fever was diagnosed with polyarteritis nodosa after 18F-FDG PET/CT revealed the characteristic “ant-farm-like” pattern previously observed in people with the condition.

👉️ buff.ly/P8s1MZH

#RheumSky

@mithurheum.bsky.socialSep 27, 2026, 10:55 PM

Enjoyed speaking at our annual Duke Lupus Community Event yesterday on “Understanding Lupus Labs” 🩸🧪

#Lupus #PatientEducation #HealthLiteracy #RheumSky

Photo, no descriptionPhoto, no description
@thelancetrheum.bsky.socialSep 25, 2026, 4:28 PM

NEW RESEARCH—Minimal residual disease flow cytometry of peripheral blood B-cell subsets in patients with idiopathic inflammatory myopathies following rituximab therapy: a single-centre, retrospective cohort study thelancet.com/journals/lan...
#MedSky #RheumSky

Photo, no description
Load more